SEC Form 3 · accession 0001104659-26-109371
Transcode Therapeutics, Inc. · RNAZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John A Tattory
Officer — Interim CFO
Period of report
Sep 10, 2026
Accepted (ET)
Sep 21, 2026 · 5:42 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001829635
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
No Table II lines on this filing.
Remarks
Exhibit 24: Power of Attorney